Red Violet (RDVT) is an Incredible Growth Stock: 3 Reasons Why — Positive

RDVT   Zacks Investment Research — May 16, 2025

Red Violet (RDVT) possesses solid growth attributes, which could help it handily outperform the market.

image for news Red Violet (RDVT) is an Incredible Growth Stock: 3 Reasons Why

3 Reasons Why Palomar (PLMR) Is a Great Growth Stock — Positive

PLMR   Zacks Investment Research — May 16, 2025

Palomar (PLMR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news 3 Reasons Why Palomar (PLMR) Is a Great Growth Stock

DALLAS--(BUSINESS WIRE)--Flowserve Corp. (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, has released the voting results of its 2025 Annual Meeting of Shareholders and announced its quarterly cash dividend. Annual Meeting Results At the virtual Annual Meeting, Flowserve's shareholders re-elected Sujeet Chand, Ruby R. Chandy, Gayla J. Delly, John L. Garrison, Cheryl H. Johnson, Michael C. McMurray, Thomas B. Okray, R. Scott Rowe, and K.

image for news Flowserve Announces Results of 2025 Annual Meeting of Shareholders and Quarterly Dividend

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=148935&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

image for news Securities Lawsuit Alert: Avis Budget Group, Inc. (CAR) - Contact Levi & Korsinsky Before June 24, 2025

Is Barclays A 'Buy' Following Its Q1 2025 Earnings? — Positive

BCS   Seeking Alpha — May 16, 2025

Barclays' operating momentum is strong, with revenue and profitability growth driven by stable retail and corporate banking and resilient net interest income. The bank's business mix is shifting toward less cyclical, more recurring revenue streams, supported by acquisitions like Tesco Bank and efficiency improvements. Barclays offers significant capital returns through buybacks, though its dividend yield remains below peers and valuation is still discounted versus other European banks.

image for news Is Barclays A 'Buy' Following Its Q1 2025 Earnings?

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. District Court for the District of Delaware ruled in favor of Acadia regarding its ‘721 formulation patent for NUPLAZID® (pimavanserin), Acadia's drug for the treatment of Parkinson's Disease Psychosis. In today's order, the Court ruled in favor of Acadia on both infringement and validity arguments in its formulation patent litigation against Aurobindo Pharma Limited and other ANDA (Abbreviated.

image for news Delaware District Court Rules in Favor of Acadia in NUPLAZID® (pimavanserin) Formulation Patent Litigation

DKS Stock Slides More Than 14% Despite Upbeat Q1 Preliminary Results — Neutral

DKS   Zacks Investment Research — May 16, 2025

DICK'S Sporting issues robust preliminary numbers for first-quarter fiscal 2025. Solid omnichannel athlete experience and unique product assortment act as catalysts.

image for news DKS Stock Slides More Than 14% Despite Upbeat Q1 Preliminary Results

The plan follows the Trump White House's recent move to tighten curbs on China's access to Nvidia's high-end AI chips.

image for news Nvidia to Set Up Research Center in Shanghai, Maintaining Foothold in China

Applied Materials Q2 Earnings: Solid Print, But Missing Clear Catalysts — Positive

AMAT   Seeking Alpha — May 16, 2025

Applied Materials delivered an in-line quarter, but lacked the upside surprises seen in peers like KLAC and LRCX. DRAM revenue declined YoY despite HBM demand expectations, raising concerns about the durability of that growth driver. China revenue dropped to 25%, helping de-risk exposure but still posing a major geopolitical risk.

image for news Applied Materials Q2 Earnings: Solid Print, But Missing Clear Catalysts

Mastercard Partners With MoonPay to Boost Stablecoin Payments — Positive

MA   Zacks Investment Research — May 16, 2025

MA teams up with MoonPay to deploy stablecoin-linked Mastercard cards, aiming to simplify global crypto payments and enhance cross-border money transfers for businesses.

image for news Mastercard Partners With MoonPay to Boost Stablecoin Payments

Dillard's Q1 Earnings Beat Estimates, Comparable Store Sales Dip 1% — Neutral

DDS   Zacks Investment Research — May 16, 2025

DDS posts earnings beat in first-quarter fiscal 2025. Comparable store sales slip 1% on weak sales in home and furniture, shoes and ladies' apparel.

image for news Dillard's Q1 Earnings Beat Estimates, Comparable Store Sales Dip 1%

Shares of Walt Disney Company ( NYSE: DIS ) soared 36.60% over the past month, outpacing the broad market's rally over the same time.

image for news Walt Disney Company (NYSE: DIS) Price Prediction and Forecast 2025-2030 (May 2025)

NEW YORK--(BUSINESS WIRE)--BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (the "Fund") today announced the final results of its quarterly tender offer (the "Tender Offer") for up to 2.5% of the Fund's issued and outstanding shares of common stock (the "Shares"). The Tender Offer, which expired at 5:00 p.m. Eastern time on May 15, 2025, was oversubscribed. Therefore, in accordance with the terms and conditions of the Tender Offer, the Fund will purchase Shares from all tendering sha.

image for news BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Final Results of Quarterly Tender Offer

Epic Games' popular video game "Fortnite" is unavailable on iOS devices around the globe after the company said Apple (AAPL) blocked its submission to return to the App Store in the U.S., and Epic Games Store internationally.

image for news Epic Games' 'Fortnite' Offline on iOS as Firm Says Apple Blocked Game's Return

Meta has asked a federal judge to throw out the FTC's landmark antitrust case – in the middle of the trial that could result in the Big Tech giant's breakup.

image for news Mark Zuckerberg's Meta asks judge to throw out FTC's antitrust case — in middle of high-stakes trial

NICE Q1 Earnings Beat Estimates on Strong Cloud Revenues, Stock Rises — Positive

NICE   Zacks Investment Research — May 16, 2025

NICE's first-quarter 2025 results highlight strong cloud revenue growth, driven by increased migration to CXone and X-Sight, and an expanding customer base.

image for news NICE Q1 Earnings Beat Estimates on Strong Cloud Revenues, Stock Rises

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=148934&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Urges BigBear.ai Holdings, Inc. (BBAI) Shareholders to Act Before Lead Plaintiff Deadline June 10, 2025

PayPal vs. Block: Which Fintech Stock is a Stronger Buy Right Now? — Positive

PYPL  XYZ   Zacks Investment Research — May 16, 2025

PayPal PYPL and Block XYZ are well-known providers of digital payments in the rapidly evolving fintech sector. Both offer peer-to-peer payments, Buy Now Pay Later (BNPL) solutions and a cryptocurrency buy-sell platform.

image for news PayPal vs. Block: Which Fintech Stock is a Stronger Buy Right Now?

NEW YORK , May 16, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Inozyme Pharma, Inc. (NASDAQ: INZY ), relating to the proposed merger with BioMarin Pharmaceutical Inc. Under the terms of the agreement, BioMarin will commence a cash tender offer to acquire all of the outstanding shares of Inozyme common stock at a price of $4.00 …

image for news SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inozyme Pharma, Inc. - INZY

NEW YORK , May 16, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Charter Communications, Inc. (NASDAQ: CHTR ), relating to the proposed merger with Cox Communications.

image for news $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Charter Communications, Inc. - CHTR